Chemoinformaics analysis of 2-HYDROXY-5-METHYLBENZOIC ACID
| Molecular Weight | 152.149 | nRot | 1 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 11 |
| Exact Molecular Weight | 152.047 | nRing | 1 |
| Solubility: LogS | -4.672 | nHRing | 0 |
| Solubility: LogP | 4.201 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 21.1003 |
| nHD | 2 | BPOL | 8.89366 |
| QED | 0.638 |
| Synth | 2.161 |
| Natural Product Likeliness | -0.031 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.018 |
| HIA | 0.003 |
| CACO-2 | -4.674 |
| MDCK | 0.0000193 |
| BBB | 0.071 |
| PPB | 0.936555 |
| VDSS | 1.245 |
| FU | 0.0827573 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.869 |
| CYP2c19-inh | 0.802 |
| CYP2c19-sub | 0.394 |
| CYP2c9-inh | 0.534 |
| CYP2c9-sub | 0.791 |
| CYP2d6-inh | 0.305 |
| CYP2d6-sub | 0.861 |
| CYP3a4-inh | 0.143 |
| CYP3a4-sub | 0.215 |
| CL | 9.477 |
| T12 | 0.268 |
| hERG | 0.008 |
| Ames | 0.291 |
| ROA | 0.141 |
| SkinSen | 0.512 |
| Carcinogencity | 0.789 |
| EI | 0.977 |
| Respiratory | 0.151 |
| NR-Aromatase | 0.641 |
| Antiviral | No |
| Prediction | 0.808153 |